Are next-generation sequencing results knocking on Heaven's door for transplantation planning in chronic myelomonocytic leukemia?

Haematologica. 2020 Mar;105(3):530-533. doi: 10.3324/haematol.2019.240853.

Authors

Guillermo F Sanz^{1

2

3

4}, Mariam Ibañez^{1

2

4

5}, Elvira Mora^{1

2}

Affiliations

¹ Department of Hematology, Hospital Universitario y Politécnico La Fe, Valencia.
² Instituto de Investigación Sanitaria La Fe, Valencia.
³ Department of Medicine, University of Valencia, Valencia.
⁴ Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid.
⁵ Departamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad CEU Cardenal Herrera, Valencia, Spain.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cytogenetic Analysis
Cytogenetics
High-Throughput Nucleotide Sequencing
Humans
Leukemia, Myelomonocytic, Chronic* / genetics
Leukemia, Myelomonocytic, Chronic* / therapy
Leukemia, Myelomonocytic, Juvenile*